Kenvue Beats First-Quarter Estimates Amid Pending Acquisition by Kimberly-Clark
RSS SUMMARY · AGGREGATED FROM BOF
Tylenol-maker Kenvue on Thursday beat Wall Street estimates for first-quarter revenue and profit helped by strong sales in its skin health and beauty brands.
Tylenol-maker Kenvue on Thursday beat Wall Street estimates for first-quarter revenue and profit helped by strong sales in its skin health and beauty brands.
Tylenol-maker Kenvue on Thursday beat Wall Street estimates for first-quarter revenue and profit helped by strong sales in its skin health and beauty brands.
Continue Reading
The full story continues on Business of Fashion.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
BOF
Lifestyle
The BoF Podcast | A Tribute to the Enduring Legacy of Mrs. B
BOF·1d ago·3 min read
Lifestyle
Examining Lauren Sánchez Bezos’s Emerging Influence on Fashion
BOF·1d ago·3 min read
Lifestyle
The Great Sustainability Rebrand
BOF·1d ago·3 min read
Lifestyle
Footwear’s Inflation Solution Is a Big Problem
BOF·1d ago·3 min read
Related
On this beat
Lifestyle
Inside Houston Rockets Owner Tilman J. Fertitta’s Art-Filled Texas Home
ROBB REPORT·1h ago·3 min read
Lifestyle
Nike Says It’s ‘Deeply Committed’ to SNKRS App After Speculation Swirls
WWD·4m ago·3 min read
Lifestyle
Major US dog food brand issues recall over possible salmonella contamination
INDEPENDENT·2h ago·3 min read
Lifestyle
What the Many Mothers of the Movies Reflect Back to Us
ELLE·3h ago·3 min read